Evaluating the Effect Of Rifaximin on the Gut Microbiota and Metabolome in SIBO Using CapScan®
Phase 1
Recruiting
- Conditions
- Small Intestinal Bacterial Overgrowth
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-07-22
- Lead Sponsor
- Envivo Bio Inc
- Target Recruit Count
- 34
- Registration Number
- NCT06298409
- Locations
- 🇺🇸
Silicon Valley Gastroenterology, Mountain View, California, United States
Evaluation of the CapScan Device to Measure the Metabolism of Sulfasalazine
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: CapScan intestinal sampling device
- First Posted Date
- 2023-03-01
- Last Posted Date
- 2024-02-06
- Lead Sponsor
- Envivo Bio Inc
- Target Recruit Count
- 10
- Registration Number
- NCT05749068
- Locations
- 🇺🇸
Silicon Valley Gastroenterology, Mountain View, California, United States
© Copyright 2025. All Rights Reserved by MedPath